Problematic Variation in Local Institutional Review of a Multicenter Genetic Epidemiology Study

JAMA

Volumn 290, Issue 3, 2003, Pages 360-366

  McWilliams, Rita ^a   Hoover Fong, Julie ^b   Hamosh, Ada ^b   Beck, Suzanne ^c,d   Beaty, Terri ^a   Cutting, Garry ^b  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

^c DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

^d ST CHRISTOPHER'S HOSPITAL FOR CHILDREN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CYSTIC FIBROSIS; DNA DETERMINATION; GENE SEQUENCE; GENETIC EPIDEMIOLOGY; GENETIC VARIABILITY; HUMAN GENOME; MEDICAL LITERATURE; MEDICAL RESEARCH; PRIORITY JOURNAL; PUBLICATION; BIOMEDICAL AND BEHAVIORAL RESEARCH; EMPIRICAL APPROACH; EPIDEMIOLOGY; ETHICS; GENETICS; GENETICS AND REPRODUCTION; HUMAN; MULTICENTER STUDY; POPULATION AND POPULATION RELATED PHENOMENA; PROFESSIONAL STANDARD; STANDARD; UNITED STATES;

BIOMEDICAL AND BEHAVIORAL RESEARCH; EMPIRICAL APPROACH; GENETICS AND REPRODUCTION;

CYSTIC FIBROSIS; EPIDEMIOLOGIC MEASUREMENTS; EPIDEMIOLOGIC RESEARCH DESIGN; EPIDEMIOLOGY, MOLECULAR; ETHICS COMMITTEES, RESEARCH; GENETIC RESEARCH; HUMANS; MULTICENTER STUDIES; UNITED STATES;

EID: 0037925635     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.290.3.360     Document Type: Article

References (41)

1. Reilly PR. Rethinking risks to human subjects in genetic research. Am J Hum Genet. 1998;63:682-685.
2. Brown J. Protecting human research subjects: status of recommendations. Report OEI-01-97-00197. April 2000. Available at: http://oig.hhs.gov/oei/reports/oei-01-97-00197.pdf. Accessíbility verified June 2, 2003.
3. Grob G. Protecting human subjects: status of recommendations. Statement to Congress. May 3, 2000. Available at: http://www.house.gov/reform/cj /hearings/00.05.03/Grob.htm. Accessibility verified June 2, 2003.
4. Jamrozik K. The case for a new system for oversight of research on human subjects. J Med Ethics. 2000;26:334-339.
5. Institute of Medicine Committee on Assessing the System for Protecting Human Research Participants. Responsible Research: A Systems Approach to Protecting Human Research Participants. Washington, DC: National Academies Press; 2003.
6. Greely HT. Human genomics research: new challenges for research ethics. Perspect Biol Med. 2001; 44:221-229.
7. Silverman H, Hull SC, Sugarman J. Variability among institutional review boards' decisions within the context of a multicenter trial. Crit Care Med. 2001;29: 235-241.
8. Stair TO, Reed CR, Radeos MS, Koski G, Camargo CA, for the MARC Investigators. Variation in institutional review board responses to a standard protocol for a multicenter clinical trial. Acad Emerg Med. 2001;8:636-641.
9. PubMed home page. Available at: http://www.ncbi.nlm.nih.gov/PubMed. Accessibility verified June 2, 2003.
10. American Society of Human Genetics Ad Hoc Committee on DNA Technology. DNA banking and DNA analysis: points to consider. 1987. Available at: http://www.faseb.org/genetics/ashg/policy/pol-02.htm. Accessibility verified June 2, 2003.
11. American Hospital Directory. Data from AHA annual survey database. Available at: http://www.ahd.com/freesearch.php3. Accessibility verified June 2, 2003.
12. National Institutes of Health Office of Extramural Research. NIH extramural awards by state and foreign site. 2001. Available at: http://grants2.nih.gov/grants/award/state/state.htm. Accessibility verified June 2, 2003.
13. SAS for Windows, Release 8.02 [computer program]. Cary, NC: SAS Institute Inc; 2001.
14. Department of Health and Human Services. Protection of human subjects. 1991. Codified at 45 CFR §46. Revised November 13, 2001. Available at: http://ohrp.osophs.dhhs.gov/humansubjects/guidance/45cfr46.htm. Accessibility verified June 16, 2003.
15. MacFadyen U. Electronic rapid response to: Lux AL, Edwards SW, Osborne JP. Responses of local research ethics committees to a study with approval from a multicentre research ethics committee. BMJ. 2000; 320:1182-1183. Available at: http://www.bmj.com/cgi/eletters/320/7243/1182. Accessibility verified June 16, 2003.
16. Office for Protection From Research Risks. Issues to consider in the research use of stored data or tissues. November 7, 1997. Available at: http://ohrp.osophs.dhhs.gov/humansubjects/guidance/reposit.htm. Accessibility verified June 2, 2003.
17. Levine RJ, Lasagna L. Demystifying central review boards: current options and future directions. IRB. 2000;22(6):1-9.
18. Morse MA, Califf RM, Sugarman J. Monitoring and ensuring safety during clinical research. JAMA. 2001;285:1201-1205.
19. US Department of Health and Human Services Office of Inspector General. Institutional review boards: a time for reform. Report OEI-01-97-00193. June 1998. Available at: http://oig.hhs.gov/oei/reports/oei-01-97-00193.pdf. Accessibility verified June 2, 2003.
20. Burman WJ, Reves RR, Cohn DL, Schooley RT. Breaking the camel's back: multicenter clinical trials and local institutional review boards. Ann Intern Med. 2001;134:152-157.
21. Christian MC, Goldberg JL, Killen J, et al. A central institutional review board for multi-institutional trials. N Engl J Med. 2002;346:1405-1408.
22. Beskow LM, Burke W, Merz JF, et al. Informed consent for population-based research involving genetics. JAMA. 2001;286:2315-2321.
23. American Association of University Professors. Protecting human beings: institutional review boards and social science research. 2000. Available at: http://www.aaup.org/statements/redbook/repirb.htm. Accessibility verified June 16, 2003.
24. Vastag B. Experts wrestle with social, ethical implications of human genome research. JAMA. 2001; 285:721-722.
25. American Society of Human Genetics, Statement on informed consent for genetic research. Am J Hum Genet. 1996;59:471-474.
26. Office for Protection from Research Risks. Institutional review board guidebook: human genetic research, 1993. Available at: http://ohrp.osophs.dhhs.gov/irb/irb_guidebook.htm. Accessibility verified June 16, 2003.
27. American College of Medical Genetics Storage of Genetics Materials Committee. Statement on storage and use of genetics materials. 1995. Available at: http://www.faseb.org/genetics/acmg/pol-17.htm.Accessibility verified June 2, 2003.
28. National Human Genome Research Institute. Institutional review board: investigators guide: section II: informed consent and assent. Available at: http://www.genome.gov/page.cfm?pagelD=10005224. Accessibility verified June 2, 2003.
29. National Institute of General Medical Sciences Human Genetic Cell Repository. Model informed consent form. Available at: http://locus.umdnj.edu/nigms/comm/submit/model.pdf. Accessibility verified June 2, 2003.
30. Centers for Disease Control and Prevention. Consent for CDC research: a reference for developing consent forms. November 1998. Available at: http://www.cdc.gov/od/ads/hsrconsent.pdf. Accessibility verified June 16, 2003.
31. Department of Health and Human Services. The human genome project. 2001. Available at: http://ohrp.osophs.dhhs.gov/nhrpac/mtg04-01/franciscollins.pdf. Accessibility verified June 20, 2003.
32. National Bioethics Advisory Commission. Research Involving Human Biological Materials: Ethical Issues and Policy Guidance. Vol 1. Rockville, Md: National Bioethics Advisory Commission; 1999.
33. Boonstra H, Nash E. Minors and the right to consent to health care. In: The Guttmacher Report on Public Policy. August 2000. Available at: http://www.guttmacher.org/pubs/journals/gr030404.pdf.
34. National Bioethics Advisory Commission. Ethical and Policy Issues in Research Involving Human Participants. Vol 1. Rockville, Md: National Bioethics Advisory Commission; 2001.
35. Steinbrook R. Improving protection for research subjects. N Engl J Med. 2002;346:1425-1430.
36. Micetich K. Reflections of an IRB chair. Camb Q Healthc Ethics. 1994;3:506-509.
37. Alberti K. Local research ethics committees: time to grab several bulls by the horns. BMJ. 1995;311: 639-640.
38. Slater EE. IRB reform. N Engl J Med. 2002;346: 1402-1404.
39. Lemmens T, Thompson A. Noninstitutional commercial review boards in North America: a critical appraisal and comparison with IRBs. IRB. 2001;23(2): 1-12.
40. Durham M. How research will adapt to HIPAA: a view from within the healthcare delivery system. Am J Law Med. 2002;28:491-502.
41. Sarraille W, Spenser A. Assembling the HIPAA privacy puzzle. Healthc Financ Manage. 2003;57:46-52.